 HAUPPAUGE, N.Y., May 06, 2021 GLOBE NEWSWIRE -- Chembio Diagnostics, Inc. Nasdaq: CEMI, a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2021. Chembio achieved first quarter 2021 total revenue of 8.7 million and product revenue of 4.0 million, representing growth of 27 and a decline of 30, respectively, compared to the prior year period. 